Hegmann TE, Walter EB, Smith MJ, Campbell J, et al. A phase I study of the safety, reactogenicity and immunogenicity of two quadrivalent seasonal influenza vaccines (Fluzone(R) or Flublok(R)) with or without one of two adjuvants (AF03 or Advax-CpG55.2) in healthy adults 18-45 years of age. Vaccine 2025;54:126991.
PMID: 40107003